Target intelligence / Profile preview

Selenoprotein O (SELENOO)

Target
SELENOO
Molecular classification
Enzyme, Selenoprotein, Mitochondrial protein, Adenylyltransferase (AMPylator), Pseudokinase (functionally considered due to some kinase-like structural features but with distinct activity)
01

Overview

Selenoprotein O (SELENOO) is the largest mammalian selenoprotein, localized to mitochondria, and contains selenocysteine (Sec), a rare amino acid encoded by a UGA stop codon using a specialized RNA structure (SECIS element)[3][4][5]. SELENOO catalyzes the covalent transfer of adenosine monophosphate (AMP) onto serine, threonine, or tyrosine residues of target proteins, a modification known as AMPylation, particularly on proteins involved in redox homeostasis[2][4]. This activity suggests SELENOO helps regulate mitochondrial redox function and the cellular response to oxidative stress, but its full physiological roles remain incompletely defined[1][2][3][4]. SELENOO is evolutionarily conserved from bacteria to humans and is grouped among the lesser-known “alphabet selenoproteins” implicated broadly in antioxidant and redox-related processes[1]. There is currently no clinical use for SELENOO as a biomarker or therapeutic target, and no drugs are known to directly interact with it.

Other names
Protein adenylyltransferase SelO, mitochondrialSELOSelenoprotein O, mitochondrialSelO
02

Biological functions

AMPylation (post-translational modification by the addition of AMP to Ser, Thr, Tyr residues on target proteins)Redox homeostasis and response to oxidative stressMitochondrial protein function/regulation
03

Disease associations

Other (There are associations with rare conditions in genetic databases, but there is no clear, established direct role in major diseases such as cancer, cardiovascular, neurodegeneration, etc. Limited evidence links SELENOO to disorders like staphyloenterotoxemia and epidermolysis bullosa simplex Ogna type, but mechanistic involvement is unclear)

Beyond the preview

Go deeper on Selenoprotein O (SELENOO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selenoprotein O (SELENOO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call